A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: A Gynecologic Oncology Group Study-Reference-Cited by-同舟云学术

A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: A Gynecologic Oncology Group Study

Published:1990-12 Issue:3 Volume:39 Page:239-243
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Creasman William T.,Omura George A.,Brady Mark F.,Yordan Edgardo,DiSaia Philip J.,Beecham Jackson

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference12 articles.

1. Cancer statistics 1990;Silverberg;Ca,1990

2. Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus Corynebacterium parvum;Gall;Gynecol. Oncol.,1986

3. Randomized study of chemoimmunotherapy for advanced ovarian carcinoma: A preliminary report of a Southwest Oncology Group Study;Alberts;Cancer Treat. Rep.,1979

4. Design, analysis and interpretation of chemotherapy trials in gynecologic cancer;Blessing,1984

5. Regression model and life tables (with discussion);Cox;J. R. Stat. Soc. B,1972

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis;Journal of Clinical Oncology;2023-09-01

2. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery;Cochrane Database of Systematic Reviews;2022-09-26

3. A BCG success story: From prevention of tuberculosis to optimal bladder cancer treatment;Vaccine;2021-12

4. Epithelial Ovarian Cancer;Clinical Gynecologic Oncology;2018

5. Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy;OncoImmunology;2012-09